A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models
Joseph M. Hoolachan(Keele University), Mélissa Bowerman(Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust)
Cited by 7
Related Papers
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice
|EBioMedicine|2018|47
Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis
|Human Molecular Genetics|2015|32
A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2
TAS1R3 Regulates GTPase Signaling in Human Skeletal Muscle Cells for Glucose Uptake
|International Journal of Molecular Sciences|2025|0